Yeh, Chau-Ting <br/><br/>
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B.  [electronic resource] 

 -  BMC cancer  Sep 2011 
 - 398 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-11-398  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antiviral Agents--adverse effects<br/>Base Sequence<br/>Carcinoma, Hepatocellular--virology<br/>DNA, Viral--blood<br/>Drug Resistance, Viral<br/>Female<br/>Hepatitis B virus--genetics<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Incidence<br/>Lamivudine--adverse effects<br/>Liver Cirrhosis<br/>Liver Neoplasms--virology<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Mutation<br/>Nucleic Acid Amplification Techniques<br/>Retrospective Studies<br/>Risk Factors